Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
Urology. 2010 Oct;76(4):866-71. doi: 10.1016/j.urology.2009.12.082. Epub 2010 May 8.
To present our technique and initial experience with patients who underwent robot-assisted intracorporeal creation of ileal conduit and to compare them with patients who underwent extracorporeal ileal diversion after robot-assisted radical cystectomy.
Twenty-six patients diagnosed with invasive transitional cell carcinoma of the bladder underwent a robot-assisted radical cystectomy with bilateral extended pelvic lymphadenectomy with ileal conduit diversion. Total intracorporeal ileal conduit creation was performed in the last 13 patients. Operative data and short-term outcomes between the 2 groups were assessed. The novel surgical technique for intracorporeal ileal conduit will be presented.
The intracorporeal group (IC) included 2 female and 11 male patients (mean age 71 years). The extracorporeal group (EC) included 4 female and 9 male patients (mean age 66 years). No significant differences were noted between the groups in terms of patient age, BMI, sex, prior surgery, or pathologic stage. Overall operative time and intraoperative complications were similar. No significant differences were noted between the 2 groups in terms of diversion time or estimated blood loss. There were 4 complications recorded in IC patients, including nonspecific colitis, small bowel obstruction requiring exploratory laparotomy with lysis of adhesions, a urine leak that eventually resolved but required a temporary nephrostomy tube, and a fever of unknown origin that resolved without intervention.
Robot-assisted intracorporeal ileal conduit can be accomplished safely with acceptable operative times even during early experience. Larger series with favorable results will be required to add this new paradigm to minimally invasive surgery for bladder cancer.
介绍我们在接受机器人辅助体内创建回肠导管的患者中应用的技术和初步经验,并与接受机器人辅助根治性膀胱切除术后进行体外回肠转流术的患者进行比较。
26 例诊断为浸润性膀胱移行细胞癌的患者接受了机器人辅助根治性膀胱切除术和双侧广泛盆腔淋巴结清扫术及回肠导管转流术。最后 13 例患者行全腹腔镜下回肠导管造口术。评估两组患者的手术数据和短期结果。将介绍一种新的体内回肠导管手术技术。
体内组(IC)包括 2 例女性和 11 例男性患者(平均年龄 71 岁)。体外组(EC)包括 4 例女性和 9 例男性患者(平均年龄 66 岁)。两组患者在年龄、BMI、性别、既往手术史或病理分期方面无显著差异。总体手术时间和术中并发症相似。两组患者在转流时间或估计失血量方面无显著差异。IC 患者中有 4 例并发症,包括非特异性结肠炎、需要剖腹探查和粘连松解的小肠梗阻、尿漏,最终自行缓解,但需要临时肾造口管、原因不明的发热,无需干预即可缓解。
即使在早期经验中,机器人辅助体内回肠导管也可以安全完成,手术时间可接受。需要更大的系列研究来获得良好的结果,以便将这一新模式添加到膀胱癌的微创外科中。